Pfizer and UK Coal cuts hit North-east with 900 job losses
Thursday 27 January 2005
The north-east of England suffered a double jobs blow yesterday as the region's last deep coal mine was shut down and a multinational drug company said it was closing a manufacturing plant in the region. More than 900 jobs will be lost around the town of Morpeth.
UK Coal, which owns the rump of the British coal industry, has closed Ellington colliery near Morpeth with the immediate loss of 340 jobs. Millions of gallons of water had flooded the current site and 13 days of pumping failed to restore the mine.
Gerry Spindler, the chief executive of UK Coal, said: "We could not have asked for, or received, more commitment than that given by the Ellington workforce, and it is a great sadness that their attempts to maintain viable deep-mine operations for some years to come have been so abruptly terminated."
The company, whose shares dipped 2p to 129.5p on news that the closure will cost £6m, said it would be unsafe to move mining to adjacent areas.
The closure brings an end to the losses at Ellington, which were £11m last year, but it is a bitter blow to the local community. It came on the same day as Pfizer, the world's largest pharmaceuticals company, said it no longer needed a manufacturing plant in Morpeth, which employs 571 people.
The company will try to find a buyer and said it would work with the Department of Trade and Industry to try to minimise the effect on the local community.
The Morpeth plant makes pharmaceutical chemicals, and tablets and capsules for heart and arthritis medicines sold around the world. The closure is part of a manufacturing review at Pfizer, which was launched after it bought Pharmacia of the US in 2003.
In Sandwich, Kent, Pfizer employees were also told yesterday that 400 jobs would go over the next few years at plants making veterinary and human cardiovascular drugs.
Tony Maddaluna, Pfizer's vice-president of global manufacturing, said: "The capacity provided by these operations is not required."
- 1 Autistic adults could take pure MDMA to 'reduce social anxiety'
- 2 Stolen Instagram photo sells for $90,000
- 3 Before you complain about your GP, this is what you need to know about actually doing the job
- 4 Charlie Charlie Challenge explained: not a Mexican demon being summoned — it's gravity
- 5 Paracetamol Challenge: Mother of girl killed by overdose pleads with teenagers not to take part
Iran launches anti-Isis cartoon competition 'to expose true nature of Islamic State'
'Don't blame all men for rape' campaign backfires spectacularly
Fifa corruption arrests: How Chuck Blazer rinsed money from the beautiful game
Fifa corruption live: Uefa to consider pulling teams from Fifa tournaments if Blatter stays
Ukip MP Douglas Carswell says he felt his safety was 'seriously at risk' after he was surrounded by anti-austerity protesters
EU referendum: David Cameron's rules are a 'democratic disgrace', says French-born Scottish politician set to be denied a vote
The day that Britain resigned as a global power
SNP fury as HS2 finds 'no business case' for taking fast train service to Scotland
Australian man punched in the face for defending Muslim women from abuse on train
A nation of inequality: How the UK is failing to feed its most vulnerable people
EU referendum: David Cameron to deny EU migrants and under-18s the chance to vote
iJobs Money & Business
£30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...
£20000 - £25000 per annum + OTE £45K YR1: SThree: At SThree, we like to be dif...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is a mul...
£55 - 65k (DOE): Guru Careers: A unique opportunity for a permanent C# Develop...